Ultragenyx Pharmaceutical (RARE) Tax Rate (2017 - 2026)
Ultragenyx Pharmaceutical (RARE) posted quarterly Tax Rate of 0.54% for Q1 2026, up 12.0% year-over-year from 0.49% in Q1 2025, and up 23.98% quarter-over-quarter from 0.71% in Q4 2025.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Tax Rate (2017 - 2026) Analysis & Trends
Ultragenyx Pharmaceutical (RARE) has reported Tax Rate for 10 consecutive years, with 0.54% the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Rate rose 12.0% year-over-year to 0.54%; the TTM figure through Mar 2026 stood at 0.62% (down 15.0% YoY), while the FY2025 annual figure was 0.71%, down 35.0% from the prior year.
- Tax Rate advanced to 0.54% in Q1 2026 per RARE's latest filing, from 0.71% in the prior quarter.
- Across five years, Tax Rate topped out at 3.04% in Q4 2023 and bottomed at 2.63% in Q3 2022.
- Historically, Tax Rate has averaged 0.36% across 5 years, with a median of 0.41% in 2023.
- Annual changes were most pronounced in 2023 — Tax Rate jumped 317 bps — and 2024, when it plunged 334 bps.
- Ultragenyx Pharmaceutical's Tax Rate stood at 0.12% in 2022, then jumped by 2568 bps to 3.04% in 2023, then slumped by 110 bps to 0.3% in 2024, then slumped by 140 bps to 0.71% in 2025, then advanced by 24 bps to 0.54% in 2026.
- Business Quant data shows RARE's Tax Rate at 0.54% in Q1 2026, 0.71% in Q4 2025, and 0.49% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Ultragenyx Pharmaceutical | 1.56 Bn | 1.27 Bn | 180.00 Mn | -1.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.10% |
| Mar 31, 2026 | -0.54% |
| Dec 31, 2025 | 96.43% |
| Sep 30, 2025 | -0.49% |
| Jun 30, 2025 | -0.88% |
| Mar 31, 2025 | -0.67% |
| Dec 31, 2024 | -1.04% |
| Sep 30, 2024 | -0.23% |
| Jun 30, 2024 | -0.66% |
| Mar 31, 2024 | -0.27% |
| Dec 31, 2023 | 3.04% |
| Sep 30, 2023 | -0.41% |
| Jun 30, 2023 | -0.46% |
| Mar 31, 2023 | -0.30% |
| Dec 31, 2022 | -0.12% |
| Sep 30, 2022 | -2.63% |
| Jun 30, 2022 | -0.19% |
| Mar 31, 2022 | -0.37% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -0.25% |